• Curis Inc CRIS.OQ reported a quarterly adjusted loss of $1.70​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-2.13. The mean expectation of six analysts for the quarter was for a loss of $1.83 per share. Wall Street expected results to range from $-2.11 to $-1.62 per share.

• Revenue rose 3.5% to $2.93 million from a year ago; analysts expected $2.28 million.

• Curis Inc's reported EPS for the quarter was a loss of $1.70​.

• The company reported a quarterly loss of $10.09 million.

• Curis Inc shares had fallen by 27.1% this quarter and lost 69.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 3.4% in the last three months.​

• In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

Wall Street's median 12-month price target for Curis Inc is 20.00

This summary was machine generated from LSEG data November 14 at 08:55 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)